Target intelligence / Profile preview

CYCS pseudogene 33 (CYCSP33)

Target: CYCSP33
Molecular classification: Other (Pseudogene)

Overview

CYCS pseudogene 33 (CYCSP33, also known as HCP33) is one of 49 cytochrome c pseudogenes identified in the human genome[2][3]. Pseudogenes in this family resemble the canonical cytochrome c gene (CYCS) but are rendered non-functional due to disablements such as truncations, frame shifts, stop codons, or sequence divergence[2][3]. These pseudogenes lack expression and do not encode proteins[2][3]. Their presence is the result of genomic duplication and retrotransposition events over evolutionary time, and they do not participate in cellular or physiological processes. CYCSP33 has no recognized significance as a molecular target in therapeutics, biomarker research, or disease biology[1][2][3].

Other names: HCP33CYCSP33

Beyond the preview

Go deeper on CYCS pseudogene 33 (CYCSP33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CYCS pseudogene 33 (CYCSP33).

Explore the full profile